Stockreport
Global Muscle Relaxant Drugs Market Size To Worth USD 5.91 Billion By 2033 | CAGR Of 4.24% [Yahoo! Finance]
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
to Reach USD 5.91 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Amneal Pharmaceuticals LLC, Ipsen Biopharmaceuticals, Inc., Merz Pharmaceuticals, LLC., Par Pharmaceutical, Vertical Pharmaceuticals, Mallinckrodt, Amgen Inc., Nexus Pharmaceuticals, Metacel Pharmaceuticals, LLC., Teva Pharmaceuticals USA, Inc., Actelion Pharmaceuticals Ltd, Sandoz International GmbH, and Other key vendors. New York, United States , July 01, 2024 (GLOBE NEWSWIRE) -- The Global Muscle Relaxant Drugs Market Size is to Grow from USD 3.90 Billion in 2023 to USD 5.91 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 4.24% during the projected period. Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4589 Muscle relaxants are used in the treatment of a wide range of disorders characterized by painful and aberrant muscular contraction. They are commonly used to treat acute musculoskeletal problems, includ
[Read more]
IMPACT SNAPSHOT | EVENT TIME: | AMGN | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
LAST PRICE | ||
VWAP | ||
High:
|
MAX UP |
High:
|
Low:
|
MAX DOWN |
Low:
|
%
|
POST NEWS RANGE |
%
|
|
PRICE CHANGE |
|
|
PRICE CHANGE PERCENTAGE |
|
|
S&P 500 (SPX) |
|
%
|
VOLUME RATIO |
%
|
VOLUME (SHARES) | ||
TICKS | ||
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
AMGN alerts
AMGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
NEWS
NEWS
- Biosimilars Market is Expected to Grow from USD 27.30 Billion 2023 to reach USD 92 Billion in 2031 | SkyQuest Technology [Yahoo! Finance][Yahoo! Finance]
- Oncolytic Viruses: Unlocking a New Era in Cancer Immunotherapy | DelveInsight [Yahoo! Finance][Yahoo! Finance]
- Trends in biopharma: the future of manufacturing [Yahoo! Finance][Yahoo! Finance]
- 1 Dividend Growth Stock to Buy and Hold for 10 Years [Yahoo! Finance][Yahoo! Finance]
- Coherus offloads Humira biosimilar Yusimry for $40m [Yahoo! Finance][Yahoo! Finance]
- More
AMGN
SEC Filings
SEC Filings
- 6/21/24 - Form 11-K
- 6/21/24 - Form 11-K
- 6/12/24 - Form S-8
- AMGN's page on the SEC website
- More